Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIN1 | Q05586 | 2/20 | 0.43 |
| ▸ | GRIN2A | Q12879 | 2/20 | 0.43 |
| ▸ | CHRM2 | P08172 | 7/20 | 0.40 |
| ▸ | CHRM4 | P08173 | 7/20 | 0.40 |
| ▸ | CHRM5 | P08912 | 7/20 | 0.40 |
| ▸ | CHRM1 | P11229 | 7/20 | 0.40 |
| ▸ | CHRM3 | P20309 | 7/20 | 0.40 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.39 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.39 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7108497 | 1.00 | GRIN1 (0.43) | GRIN1GRIN2ACHRM2CHRM4CHRM5 | |
| SCHEMBL11369540 | 0.94 | MAPK1 (0.39) | GRIN1GRIN2A | |
| SCHEMBL6347170 | 0.90 | SLC6A2 (0.42) | GRIN1GRIN2ACHRM2CHRM4CHRM5 | |
| SCHEMBL6351533 | 0.84 | SLC6A2 (0.40) | SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL13221438 | 0.81 | SLC6A3 (0.40) | SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL38663972 | 0.80 | SLC6A3 (0.47) | SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL22261434 | 0.79 | NPC1 (0.34) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL15823722 | 0.79 | CHRNA1 (0.35) | GRIN1GRIN2ASLC6A2SLC6A4SLC6A3 | |
| SCHEMBL27479696 | 0.78 | GRIN1 (0.33) | GRIN1GRIN2ACHRM2CHRM4CHRM5 | |
| SCHEMBL6848854 | 0.76 | SLC6A4 (0.52) | CHRM2CHRM1SLC6A2SLC6A4SLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111217769-B | Method for synthesizing epoxy compound by catalyzing olefin epoxy by using nano alumina | 华南理工大学 | 2023-04-21 | — | — | CN | claimed |
| EP-1276733-A1 | METHOD FOR EPOXIDIZING OLEFINS | MERCK PATENT GmbH (DE) | 2003-01-22 | — | — | EP | claimed |
| WO-2001083466-A1 | METHOD FOR EPOXIDIZING OLEFINS | MERCK PATENT GMBH (DE) | 2001-11-08 | — | — | WO | claimed |
| CN-118459511-A | Metallocene complex and application thereof, preparation method of olefin polymer and ethylene/alpha-olefin copolymer | 贝欧亿(山东)新材料有限公司 | 2024-08-09 | — | — | CN | disclosed |
| CN-111217769-B | Method for synthesizing epoxy compound by catalyzing olefin epoxy by using nano alumina | 华南理工大学 | 2023-04-21 | — | — | CN | disclosed |
| EP-2216312-B1 | PROCESS FOR PRODUCING ORGANIC COMPOUND | M TECHNIQUE CO LTD (JP) | 2019-05-01 | — | — | EP | disclosed |
| US-8877930-B2 | Continuous flow synthesis of amino alcohols using microreactors | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2014-11-04 | — | — | US | disclosed |
| US-8877930-B2 | Continuous flow synthesis of amino alcohols using microreactors | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2014-11-04 | — | — | US | disclosed |
| US-8592498-B2 | Method for producing organic compound and organic compound obtained by the method | M. TECHNIQUE CO., LTD. (JP) | 2013-11-26 | — | — | US | disclosed |
| US-8227640-B2 | Palladium catalysts | INSTITUTE OF BIOENGINEERING AND NANOTECHNOLOGY (SG) | 2012-07-24 | — | — | US | disclosed |
| US-20110178199-A1 | METHOD FOR PRODUCING ORGANIC COMPOUND AND ORGANIC COMPOUND OBTAINED BY THE METHOD | M. TECHNIQUE CO., LTD. (JP) | 2011-07-21 | — | — | US | disclosed |
| CN-1198157-A | Dinaphtazepinium salts useful as enantioselective epoxidation catalysts | UNIV SHEFFIELD (GB) | 1998-11-04 | — | — | CN | disclosed |
| WO-1998033786-A1 | ACCELERATED CATALYSIS OF OLEFINIC EPOXIDATIONS | THE SCRIPPS RESEARCH INSTITUTE (US) | 1998-08-06 | — | — | WO | disclosed |
| EP-0843664-A1 | DINAPHTAZEPINIUM SALTS USEFUL AS ENANTIOSELECTIVE EPOXIDATION CATALYSTS | The University of Sheffield (GB) | 1998-05-27 | — | — | EP | disclosed |
| WO-1998015544-A1 | CATALYTIC ASYMMETRIC EPOXIDATION | COLORADO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 1998-04-16 | — | — | WO | disclosed |
| WO-1997006147-A1 | DINAPHTAZEPINIUM SALTS USEFUL AS ENANTIOSELECTIVE EPOXIDATION CATALYSTS | THE UNIVERSITY OF SHEFFIELD (GB) | 1997-02-20 | — | — | WO | disclosed |
| EP-0272421-B1 | COLOR STABILIZED IRRADIATED POLYCARBONATE COMPOSITIONS | GENERAL ELECTRIC COMPANY (US) | 1993-03-03 | — | — | EP | disclosed |
| US-4894401-A | DISCOLORATION INHIBITION | GENERAL ELECTRIC COMPANY (US) | 1990-01-16 | — | — | US | disclosed |
| US-4873278-A | Inhibition of irradiation yellowing in polysulfone compositions | GENERAL ELECTRIC COMPANY (US) | 1989-10-10 | — | — | US | disclosed |
| EP-0272421-A2 | Color stabilized irradiated polycarbonate compositions | GENERAL ELECTRIC COMPANY (US) | 1988-06-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110178199-A1 | METHOD FOR PRODUCING ORGANIC COMPOUND AND ORGANIC COMPOUND OBTAINED BY THE METHOD | OR10J3, PORCN, ABCG2 | GRIN1 3663/4885GRIN2A 3942/4885CHRM2 2707/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.